click below
click below
Normal Size Small Size show me how
Week 5 defs and drug
| Question | Answer |
|---|---|
| Codeine | the most commonly used opioid in dentistry |
| codeine + tylenol | Tylenol 3, provides greater pain relief |
| cocaine | abusers exhibit dilated pupils (mydriasis) |
| morphine | first natural opiate used for acute or severe pain |
| oxycodone | semi-synthetic opioid |
| oxycodone+acetaminophen | percocet |
| oxycodone + aspirin | percodan |
| naloxone (narcan) | opioid antagonist and used to treat opioid overdose |
| agonists | a substance that binds to and activates a receptor in the body |
| mixed opioids | mixed agonist-antagonist opioids, refer to a class of opioids that have both agonistic (activating) and antagonistic (blocking) effects on opioid receptors in the nervous system. |
| antagonists | substances that bind to receptors in the body but do not actiate them. Instead, they block or inhibit the action of agonists |
| narcotics | original name for opioid drugs. Derived from the Greek word which means "Inducing stupor or sleep." |
| opioid agonists | morphine (MS Contin, Kadian, Roxanol, Duramorph) |
| Opioid Agonists | oxycodone (acetaminophen/oxycodone) (Percocet) |
| Opioid Agonists | hydrocodone (acetaminophen/hydrocodone) (Vicodin) |
| Opioid Agonists | Codeine (codeine 15) |
| Opioid Agonists | methadone (methadose) |
| Opioid Agonists | fentanyl (Duragesic, Actiq, Subsys, Sublimaze) |
| opioid antagonists | naloxone (narcan) |
| mixed opioids | buprenorphine (buprenex) |
| mixed opioids | tramadol (ultram) |
| Abstinence sydnrome | a constellation of physiologic changes undergone by people who have become physically dependent on a drug or chemical who are abruptly deprived of that substance. |
| addiction | a chronic, relapsing brain disease that is characterized by compulsive drug-seeking use despite complications or negative consequences |
| substance use disorders | occur when the recurrent use of alcohol and/or drugs causes clinically and functionally significant impairement |
| enabling | the behavior of family or friends who associate with the addict that results in continued substance use disorder |
| habituation | physiologic tolerance to or psychological dependence on a drug |
| misues | use of a drug for a disease state in a way considered inappropriate |
| physical/physiologic depndence | the state in which the drug is necessary for the continued functioning of certain body processes |
| psychologic dependence | the state in which, following withdrawal of the drug, there are manifestations of emotional abnormalities and drug-seeking behavior |
| relapse | the return to drug use after an attempt to stop |
| tolerance | with repeated dosing, the dose of a drug must be increased to obtain the same effect |
| withdrawal | the constellation of symptoms as specified in the DMS-5 that occurs when a physically dependent person stops taking the drug |
| mixed opioid: CNS Depressants | ethyl alcohol |
| opioid analgesic: agonists | heroin |
| opioid analgesic: agonists | meperidine (Demerol) |
| benzodiazepine: Sedative-hypnotics | diazepam (Valium) |
| CNS stimulants | Cocaine |
| CNS stimulants | methamphetamine (Desoxyn) |
| CNS stimulants | Caffeine (Stay Awake) |
| CNS stimulants | Nicotine (Nicorette, Nicoderm) |
| Withdrawal Drugs | Norepinephrine-dopamine reuptake inhibitor (NDRI) |
| withdrawal drugs | bupropion (Wellbutrin SR) |
| nicotine receptor partial agonists | varenicline (Chantix) |
| Psychedelics (Hallucinogens) | lysergic acid diethylamide (LSD) |
| Psychedelics (Hallucinogens) | phencyclidine (PCP) |
| Psychedelics (Hallucinogens) | Ecstasy |
| Psychedelics (Hallucinogens) | Cannabis (Marijuana) |